Downregulation of tumor growth and invasion by redox-active nanoparticles

Antioxidants and Redox Signaling

Volumn 19, Issue 8, 2013, Pages 765-778

  Alili, Lirija ^a   Sack, Maren ^a   Von Montfort, Claudia ^a,b   Giri, Shailendra ^c   Das, Soumen ^d   Carroll, Kate S ^e   Zanger, Klaus ^f   Seal, Sudipta ^d   Brenneisen, Peter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b INST D INVESTIGACIONS B   (Spain)

^c Mayo Clinic College of Medicine   (United States)

^d UNIVERSITY OF CENTRAL FLORIDA   (United States)

^e TSRI Scripps Florida   (United States)

^f Department of Orthopedic Surgery   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CERIUM OXIDE NANOPARTICLE; DEXTRAN; NANOPARTICLE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA CELL; TUMOR INVASION; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CAVEOLIN 1; CELL LINE, TUMOR; CELL PROLIFERATION; CERIUM; DOWN-REGULATION; FIBROBLASTS; HUMANS; MELANOMA; MICE; MICE, NUDE; NANOPARTICLES; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; OXIDATION-REDUCTION; PROTEIN CARBONYLATION; REACTIVE OXYGEN SPECIES; SKIN NEOPLASMS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84875114271     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4831     Document Type: Article

References (66)

1. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, and Lawley TJ. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99: 683-690, 1992.
2. Alili L, Karakoti AS, Seal S, and Brenneisen P. Suppression of tumor invasion by inorganic nanoparticles Cancer Res 69(23 Suppl); 42, 2009.
3. Alili L, Sack M, Karakoti AS, Teuber S, Puschmann K, Hirst SM, Reilly CM, Zanger K, Stahl W, Das S, Seal S, and Brenneisen P. Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions. Biomaterials 32: 2918-2929, 2011.
4. Altekruse SF, KC, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, and Edwards BK. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute 2010.
5. Bardos JI and Ashcroft M. Negative and positive regulation of HIF-1: a complex network. Biochim Biophys Acta 1755: 107-120, 2005.
6. Bayreuther K, Francz PI, Gogol J, and Kontermann K. Terminal differentiation, aging, apoptosis, and spontaneous transformation in fibroblast stem cell systems in vivo and in vitro. Ann N Y Acad Sci 663: 167-179, 1992.
7. Bhatia S, Tykodi SS, and Thompson JA. Treatment of metastatic melanoma: an overview. Oncology (Williston Park) 23: 488-496, 2009.
8. Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S, and Smulson M. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 274: 22932-22940, 1999.
9. Brenneisen P, Wenk J, Klotz LO, Wlaschek M, Briviba K, Krieg T, Sies H, and Scharffetter-Kochanek K. Central role of ferrous/ferric iron in the ultraviolet B irradiation-mediated signaling pathway leading to increased interstitial collagenase (matrix-degrading metalloprotease (MMP)-1) and stromelysin-1 (MMP-3) mRNA levels in cultured human dermal fibroblasts. J Biol Chem 273: 5279-5287, 1998.
10. Cat B, Stuhlmann D, Steinbrenner H, Alili L, Holtkotter O, Sies H, and Brenneisen P. Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. J Cell Sci 119: 2727-2738, 2006.
11. Celardo I, Traversa E, and Ghibelli. Cerium oxide nanoparticles: a promise for applications in therapy. J Exp Ther Oncol 9: 47-51, 2011.
12. Deshpande S, Patil S, Kuchibhatla, SV, and Seal S. Size dependency variation in lattice parameter and valency states in nanocrystalline cerium oxide. Appl Phys Lett 87: 133113, 2005.
13. De Wever O and Mareel M. Role of myofibroblasts at the invasion front. Biol Chem 383: 55-67, 2002.
14. Fang J, Nakamura H, and Iyer AK. Tumor-targeted induction of oxystress for cancer therapy. J Drug Target 15: 475-486, 2007.
15. Freitas RA, Jr. What is nanomedicine? Nanomedicine 1: 2-9, 2005.
16. Fruehauf JP and Trapp V. Reactive oxygen species: an Achilles' heel of melanoma? Expert Rev Anticancer Ther 8: 1751-1757, 2008.
17. Gao W, Xu K, Ji L, and Tang B. Effect of gold nanoparticles on glutathione depletion-induced hydrogen peroxide generation and apoptosis in HL7702 cells. Toxicol Lett 205: 86-95, 2011.
18. Garbe C and Leiter U. Melanoma epidemiology and trends. Clin Dermatol 27: 3-9, 2009.
19. Garbe C, Terheyden P, Keilholz U, Kolbl O, and Hauschild A. Treatment of melanoma. Dtsch Arztebl Int 105: 845-851, 2008.
20. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, and Parks WP. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51: 1417-1423, 1973.
21. Heckert EG, Karakoti AS, Seal S, and Self WT. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials 29: 2705-2709, 2008.
22. Helmlinger G, Yuan F, Dellian M, and Jain RK. Interstitial pH and pO2 gradients in solid tumors in vivo: highresolution measurements reveal a lack of correlation. Nat Med 3: 177-182, 1997.
23. Jahroudi N and Greenberger JS. The role of endothelial cells in tumor invasion and metastasis. J Neurooncol 23: 99-108, 1995.
24. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, and Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
25. Kappus H and Sies H. Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation. Experientia 37: 1233-1241, 1981.
26. Karakoti AS, Satyanarayana VN, Kuchibhatla T, Babu KS, and Seal S. Direct synthesis of nanoceria in aqueous polyhydroxyl solutions. J Phys Chem C 111: 17232-17240, 2007.
27. Karakoti AS, Monteiro-Riviere NA, Aggarwal R, Davis JP, Narayan RJ, Self WT, McGinnis J, and Seal S. Nanoceria as antioxidant: synthesis and biomedical applications. Jom (1989) 60: 33-37, 2008.
28. Karakoti AS, Singh S, Dowding JM, Seal S, and Self WT. Redox-active radical scavenging nanomaterials. Chem Soc Rev 39: 4422-4432, 2010.
29. Kawiak A, Zawacka-Pankau J, Wasilewska A, Stasilojc G, Bigda J, and Lojkowska E. Induction of apoptosis in HL-60 cells through the ROS-mediated mitochondrial pathway by Ramentaceone from Drosera aliciae. J Nat Products 75: 9-14, 2012.
30. Kietzmann T and Gorlach A. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol 16: 474-486, 2005.
31. Korsvik C, Patil S, Seal S, and Self WT. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun (Camb) 10: 1056-1058, 2007.
32. Kuchibhatla S, Karakoti AS, Bera D, and Seal S. One dimensional nanostructured materials. Prog Mater Sci 52: 699-913, 2007.
33. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
34. Laurent A, Nicco C, Chereau C, Goulvestre C, Alexandre J, Alves A, Levy E, Goldwasser F, Panis Y, Soubrane O, Weill B, and Batteux F. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 65: 948-956, 2005.
35. Levi F, Boffetta P, and La Vecchia C. High constant incidence rates of second primary neoplasms. Eur J Cancer Prev 17: 385-388, 2008.
36. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, and Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997.
37. Lin W, Huang YW, Zhou XD, and Ma Y. Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int J Toxicol 25: 451-457, 2006.
38. Luanpitpong S, Talbott SJ, Rojanasakul Y, Nimmannit U, Pongrakhananon V, Wang L, and Chanvorachote P. Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1. J Biol Chem 285: 38832-38840, 2010.
39. Ma1ecki JM, Bentke A, Ostrowska B, and Laidler P. Cytochalasin D, LY294002 and olomoucine synergize in promoting death of melanoma cells through activation of caspase-3 and apoptosis. Melanoma Res 20: 52-58, 2010.
40. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
41. Nagata S. Apoptosis by death factor. Cell 88: 355-365, 1997.
42. Nangaku M, Izuhara Y, Takizawa S, Yamashita T, Fujii-Kuriyama Y, Ohneda O, Yamamoto M, van Ypersele de Strihou C, Hirayama N, and Miyata T. A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia. Arterioscler Thromb Vasc Biol 27: 2548-2554, 2007.
43. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, and Mason DY. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 43: 752-757, 1990.
44. Pirmohamed T, Dowding JM, Singh S, Wasserman B, Heckert E, Karakoti AS, King JES, Seal S, and Self WT. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem Commun 46: 2736-2738, 2010.
45. Quiles JL, Huertas JR, Battino M, Mataix J, and Ramirez-Tortosa MC. Antioxidant nutrients and adriamycin toxicity. Toxicology 180: 79-95, 2002.
46. Reynolds ES. Use of lead citrate at high Ph as an electronopaque stain in electron microscopy. J Cell Biol 17: 208, 1963.
47. Roberts RA, Smith RA, Safe S, Szabo C, Tjalkens RB, and Robertson FM. Toxicological and pathophysiological roles of reactive oxygen and nitrogen species. Toxicology 276: 85-94, 2010.
48. Ruas JL and Poellinger L. Hypoxia-dependent activation of HIF into a transcriptional regulator. Semin Cell Dev Biol 16: 514-522, 2005.
49. Sanchez Y, Amran D, de Blas E, and Aller P. Regulation of genistein-induced differentiation in human acute myeloid leukaemia cells (HL60, NB4) Protein kinase modulation and reactive oxygen species generation. Biochem Pharmacol 77: 384-396, 2009.
50. Saphir A. Angiogenesis: the unifying concept in cancer? J Natl Cancer Inst 89: 1658-1659, 1997.
51. Seo YH and Carroll KS. Profiling protein thiol oxidation in tumor cells using sulfenic acid-specific antibodies. Proc Natl Acad Sci U S A 106: 16163-16168, 2009.
52. Sies H. Strategies of antioxidant defense. Eur J Biochem 215: 213-219, 1993.
53. Sies H and Cadenas E. Oxidative stress-damage to intactcells and organs. Philos Transact R Soc London Ser B Biol Sci 311: 617-631, 1985.
54. Stolk J, Hiltermann TJ, Dijkman JH, and Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol 11: 95-102, 1994.
55. Storz P. Reactive oxygen species in tumor progression. Front Biosci 10: 1881-1896, 2005.
56. Stuhlmann D, Ale-Agha N, Reinehr R, Steinbrenner H, Ramos MC, Sies H, and Brenneisen P. Modulation of homologous gap junctional intercellular communication of human dermal fibroblasts via a paracrine factor(s) generated by squamous tumor cells. Carcinogenesis 24: 1737-1748, 2003.
57. Swietach P, Vaughan-Jones RD, and Harris AL. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 26: 299-310, 2007.
58. Tang Y, Zeng X, He F, Liao Y, Qian N, and Toi M. Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer. Med Oncol 29: 977-984, 2012.
59. Thannickal VJ, Aldweib KDL, and Fanburg BL. Tyrosine phosphorylation regulates H2O2 production in lung fibroblasts stimulated by transforming growth factor beta 1. J Biol Chem 273: 23611-23615, 1998.
60. Thannickal VJ and Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005-L1028, 2000.
61. Thompson TC, Tahir SA, Li L, Watanabe M, Naruishi K, Yang G, Kadmon D, Logothetis CJ, Troncoso P, Ren C, Goltsov A, and Park S. The role of caveolin-1 in prostate cancer: clinical implications. Prostate Cancer Prostatic Dis 13: 6-11, 2010.
62. Tomayko MM and Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24: 148-154, 1989.
63. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84, 2007.
64. Wittgen HG and van Kempen LC. Reactive oxygen species in melanoma and its therapeutic implications. Melanoma Res 17: 400-409, 2007.
65. Woiniak A, Drewa G, Wozniak B, Schachtschabel DO, Mila-Kierzenkowska C, Drewa T, Olszewska-Slonina D, and Soponska M. The effect of antitumor drugs on oxidative stress in B16 and S91 melanoma cells in vitro. Med Sci Monit 11: BR22-BR29, 2005.
66. Zhou M, Diwu Z, Panchuk-Voloshina N, and Haugland RP. A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Biochem 253: 162-168, 1997.